CERS4 and metabolic dysfunction-associated steatotic liver disease: Mutations in PLA2R1 rs35771982 and CERS4 rs17160348 are associated with susceptibility to MASLD in nonobese individuals, while PLA2R1 rs35771982 mutation is a risk factor for moderate-to-severe steatosis and steatohepatitis in nonobese patients.